Marpai, Inc. (MRAI)
Sector: Services-Misc Health & Allied Services, NEC
Industry: Medical - Healthcare Plans
Marpai, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 1.70 | 1.72 | 1.14 | 1.35 | 123,193 |
| Nov 16, 2026 | 1.95 | 1.95 | 1.67 | 1.72 | 44,211 |
| Nov 13, 2026 | 2.28 | 2.40 | 1.89 | 1.92 | 138,620 |
| Nov 12, 2026 | 2.52 | 2.52 | 2.28 | 2.28 | 12,130 |
| Nov 11, 2026 | 2.44 | 2.50 | 2.43 | 2.47 | 12,472 |
| Nov 10, 2026 | 2.70 | 2.70 | 2.41 | 2.44 | 11,784 |
| Nov 9, 2026 | 2.82 | 2.82 | 2.62 | 2.62 | 75,411 |
| Nov 6, 2026 | 2.73 | 2.85 | 2.73 | 2.73 | 24,126 |
| Nov 5, 2026 | 2.70 | 2.88 | 2.65 | 2.79 | 8,569 |
| Nov 4, 2026 | 2.90 | 2.90 | 2.70 | 2.70 | 12,936 |
| Nov 3, 2026 | 2.84 | 2.90 | 2.73 | 2.73 | 5,486 |
| Nov 2, 2026 | 3.00 | 3.00 | 2.72 | 2.78 | 23,425 |
| Oct 30, 2026 | 3.06 | 3.09 | 2.74 | 2.96 | 42,767 |
| Oct 29, 2026 | 2.90 | 3.06 | 2.90 | 3.06 | 19,644 |
| Oct 28, 2026 | 3.03 | 3.04 | 2.78 | 2.88 | 33,479 |
| Oct 27, 2026 | 3.11 | 3.11 | 3.03 | 3.04 | 10,224 |
| Oct 26, 2026 | 3.13 | 3.34 | 3.10 | 3.11 | 12,813 |
| Oct 23, 2026 | 3.20 | 3.20 | 3.13 | 3.13 | 4,035 |
| Oct 22, 2026 | 3.17 | 3.20 | 3.17 | 3.17 | 2,913 |
| Oct 21, 2026 | 3.18 | 3.32 | 3.18 | 3.20 | 1,979 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 1.1K | $682 | Jun 2, 2026 | |
| Director | Grant/Award | 175.0K | -- | May 29, 2026 | |
| Director | Grant/Award | 100.0K | -- | May 29, 2026 | |
| Director | Grant/Award | 125.0K | -- | May 29, 2026 | |
| Chief Executive Officer | Grant/Award | 300.0K | -- | May 29, 2026 | |
| Chief Financial Officer | Grant/Award | 125.0K | -- | May 29, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Damien Lamendola · may incl. warrants· filed Oct 2025 | 7.5M | 27.9% | 13D |
Intelligent Fanatics Capital Management LLC · may incl. warrants· filed Feb 2026 | 1.0M | 3.8% | 13G |
Johnson Steve Andrew Chief Financial Officer | 1.0M | 3.8% | FORM 4 |
Yaron Eitan · may incl. warrants· filed Dec 2024 | 908.5K | 3.4% | 13D |
SHIV SAGIV Director | 613.7K | 2.3% | FORM 4 |
TALL PINES CAPITAL, LLC · may incl. warrants· filed Oct 2025 | 545.8K | 2.0% | 13G |
PONS ROBERT M Director | 484.2K | 1.8% | FORM 4 |
Powers John Paul President and COO | 410.0K | 1.5% | FORM 4 |
Scrip Dallas Chief Operating Officer | 300.0K | 1.1% | FORM 4 |
DiClaudio Colleen Director | 267.5K | 1.0% | FORM 4 |
Insiders
- Johnson Steve AndrewChief Financial Officer
- EITAN YARONDirector
- Calabrese Jennifer RosarioDirector
- DiClaudio ColleenDirector
- Lamendola DamienChief Executive Officer
- PONS ROBERT MDirector
- SHIV SAGIVDirector
- Scrip DallasChief Operating Officer
- Intelligent Fanatics Capital Management LLC10% Owner
- Powers John PaulPresident and COO
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel.
The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures.
Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
28.79K
60d Avg
24.70K
90d Avg
49.07K
Signal8's dilution snapshot of MRAI as of Sep 30, 2026 records 5 outstanding warrant series and a PIPE closed Jul 31, 2026, from SEC filings. Marpai, Inc. (OTC: MRAI) traded at $1.35 on Nov 17, 2026, down 21.51% from the previous close of $1.72. 52-week range: $0.2150 to $4.16. The company is in the Healthcare sector (Medical - Healthcare Plans).